[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay Thomas Backstrom M.D., M.P.H.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1071673, "exercisedValue": 0, "unexercisedValue": 3439375}, {"maxAge": 1, "name": "Ms. Tracey M. Sacco M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 548855, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa Amaya Price", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Moore CPA", "age": 49, "title": "Senior Vice President of Finance", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Iarrobino", "title": "Senior Vice President of Clinical Development & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.88, "open": 33.88, "dayLow": 33.315, "dayHigh": 34.92, "regularMarketPreviousClose": 33.88, "regularMarketOpen": 33.88, "regularMarketDayLow": 33.315, "regularMarketDayHigh": 34.92, "payoutRatio": 0.0, "beta": 0.603, "forwardPE": -15.795348, "volume": 779845, "regularMarketVolume": 779845, "averageVolume": 932391, "averageVolume10days": 984950, "averageDailyVolume10Day": 984950, "bid": 33.89, "ask": 34.1, "bidSize": 1, "askSize": 2, "marketCap": 3215224064, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 39.3181, "twoHundredDayAverage": 24.227526, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2835496704, "profitMargins": 0.0, "floatShares": 69872398, "sharesOutstanding": 94676800, "sharesShort": 15951853, "sharesShortPriorMonth": 15600497, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.1685, "heldPercentInsiders": 0.01189, "heldPercentInstitutions": 1.16539, "shortRatio": 20.16, "shortPercentOfFloat": 0.3089, "impliedSharesOutstanding": 94676800, "bookValue": 3.929, "priceToBook": 8.643421, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -246294000, "trailingEps": -2.47, "forwardEps": -2.15, "enterpriseToEbitda": -11.337, "52WeekChange": 1.0595744, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 33.96, "targetHighPrice": 57.0, "targetLowPrice": 45.0, "targetMeanPrice": 50.5, "targetMedianPrice": 50.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 437278016, "totalCashPerShare": 4.619, "ebitda": -250116992, "totalDebt": 65126000, "quickRatio": 9.362, "currentRatio": 9.612, "debtToEquity": 17.667, "returnOnAssets": -0.40087003, "returnOnEquity": -0.82948, "grossProfits": -184550000, "freeCashflow": -111554872, "operatingCashflow": -200948992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "corporateActions": [], "regularMarketTime": 1742414305, "regularMarketChangePercent": 0.23612164, "regularMarketPrice": 33.96, "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "exchange": "NMS", "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "regularMarketChange": 0.07999802, "regularMarketDayRange": "33.315 - 34.92", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 932391, "fiftyTwoWeekLowChange": 27.199999, "fiftyTwoWeekLowChangePercent": 4.0236683, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -13.02, "fiftyTwoWeekHighChangePercent": -0.27713922, "fiftyTwoWeekChangePercent": 105.957436, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1740662100, "earningsCallTimestampEnd": 1740662100, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.47, "epsForward": -2.15, "epsCurrentYear": -2.62386, "priceEpsCurrentYear": -12.942764, "fiftyDayAverageChange": -5.358101, "fiftyDayAverageChangePercent": -0.13627568, "twoHundredDayAverageChange": 9.732473, "twoHundredDayAverageChangePercent": 0.4017114, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]